Novartis on Friday posted adjusted net income well above analyst estimates as sales of established heart failure drug ...

Cigna Group shares slumped after the health insurer reported cost pressures from surprisingly high catastrophic medical ...

Equitable access to quality health care should be a fundamental right. For many across New York, however, acupuncture care is restricted. While some may have health insurance policies that provide ...

Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform ...

Kentucky handed out its first two medical marijuana cards on Thursday. In addition, Gov. Andy Beshear announced that about ...

Simon Day has created some of the most memorable characters in recent British comedy history: among them competitive dad, inspired by a father in his local swimming pool thrashing his kids in a race, ...

RHHBY records impressive sales growth in 2024 on the back of strong demand for Vabysmo, Hemlibra, Phesgo and Ocrevus.

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

ECTRIMS and EBMT said stem cell transplant can be considered for some with RRMS, such as those who are younger and have less severe disease.

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

Launched in 2018, the Morningstar Minority Empowerment Index highlights companies that demonstrate a strong commitment to ...

Vertex Pharmaceuticals (VRTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Terence ...